Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
follow the official INSERM scales. The position provides opportunities for independence, international networking, and leadership development in preparation for future fellowships. Eligibility criteria
-
Behavior" team headed by François Tronche and Sébastien Parnaudeau. He/she will develop a project centered on microglia in relation to stress-related behavioral and cognitive adaptations. The specific aims
-
in oncology against breast cancer, with an ADC as active as Enhertu® in vivo but more stable during plasma circulation. The goal of this new project is to go even further by exploring the development
-
12 Feb 2026 Job Information Organisation/Company Inserm PACA Corsica Department iBV - U1091 Research Field Biological sciences » Biology Researcher Profile First Stage Researcher (R1) Positions
-
targets to develop new immune therapies toward "HIV-Cure". The project implies pDC and sub-population purification, preparation of the cells for sequencing (encapsulation and sequencing done by the Genom'IC
-
CNRS and INSERM. It is part of an internationally recognized institution focused on cutting-edge research in computational biology, cancer, and infectious diseases. The team combines expertise from
-
representativeness. The objective of the Curie Institute Research Center is to develop basic research and to use the knowledge produced to improve the diagnosis, prognosis, and therapeutics of cancers as part of
-
the impact of diet and physical activity on the development of a beneficial gut microbiota, capable of limiting uraemic sarcopenia in patients with CKD. The secondary objective is to identify human
-
Job related to staff position within a Research Infrastructure? No Offer Description The Grenoble Institute of Neurosciences (GIN, Inserm U1216, Université Grenoble Alpes) is a multidisciplinary
-
Unit, UMR 8199/ U1283 CNRS, INSERM, Institut Pasteur de Lille, CHU Lille, Université Lille) in the “Metabolome, Microbiome and Metabolic Diseases” team and the metabolomic platform IMPACT-PM, directed by